---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-097517"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2026-08-17T10:42:37+00:00"
generated_at: "2026-08-17T10:45:16.323006+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Accendra Health scraps ATM program, sells non-core assets for $45M, targets CEO successor by mid-September

## Summary
- Company will not implement at-the-market equity program; no impact on results or published guidance.
- Two non-core asset sales: first closed in Q3, second expected by year-end; ~$45M combined cash in Q3/Q4.
- Undrawn on $300M revolving credit facility at end of Q2; confident in liquidity position.
- CEO Pesicka to retire by end of 2026; Board expects to name successor by mid-September 2026.
- Pesicka remains CEO until successor in place, then advisory role for orderly transition.

## SEC filing metadata
- accession: 0001104659-26-097517
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2026-08-17T10:42:37+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/0001104659-26-097517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000110465926097517/tm2622667d5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-097517
- JSON: https://secwatch.observer/filing/0001104659-26-097517.json
- Plain text: https://secwatch.observer/filing/0001104659-26-097517.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.